Skip Ribbon Commands
Skip to main content
Menu
Adj Asst Prof Chong Siew Le

Adj Asst Prof Chong Siew Le

MD, MRCPCH (Paed) (UK)

Senior Consultant

KK Women's and Children's Hospital

Specialty: Nephrology, Paediatric Nephrology

Conditions Treated by this Doctor:
Acute and Chronic Kidney Disease including dialysis for acute kidney injury, Bedwetting, Congenital Anomalies of the Kidney and Urinary Tract (CAKUT), Fluid and Electrolyte Problems including Tubulopathies, Fluid, Electrolyte and Acid-Base Problems including Renal Tubular Acidosis and Tubulopathies, General Paediatrics, Glomerulonephritis and Glomerular Diseases including Nephrotic Syndrome, Microhaematuria and Proteinuria, Haematuria (Blood in the urine), Hypertension, Hypertension, Imaging Tests for Urinary Tract Infections (Children), Kidney Biopsy in Children, Kidney Swelling (Hydronephrosis), Nephrotic Syndrome, Nephrotic Syndrome (Children), Reflux Nephropathy, Renal Failure, Urinary Tract Infection (Child), Vesicoureteric Reflux, Voiding Dysfunction including Bedwetting/Nocturnal Enuresis.

Clinical Appointments

  • Senior Consultant Nephrology Service (Kidney Diseases) KK Women's and Children's HospitalKK Women's and Children's Hospital

Profile

Dr Chong Siew Le is a consultant pediatric nephrologist.

She received her pediatric post graduate training in Singapore and underwent pediatric nephrology fellowship training at Hospital of Sick Children, Toronto, Canada from 2009-2010, under the Health Manpower Development Plan (HMDP) Award from SingHealth.

Dr Chong is a clinician with keen interest in education and clinical research. She holds academic appointment with three Medical Schools in Singapore: Adjunct Assistant Professor of Duke-NUS and NUS School of Medicine (YLLSOM) and Adjunct Instructor of LKC. She is also actively involved in the post-graduates training as a member of the clinical Faculty in Singapore Pediatrics Residency Program. She participated actively as a co-investigator in multinational research trials.

Dr. Chong is a proponent of the Singhealth's mission statement; "Care to Heal, Educate to Empower and Innovate to Advance."

Education

  • M.D. (2000 Malaysia)
  • MRCPCH (2005 UK)
  • Followship in pediatric nephrology (2010 Toronto, Canada)
  • Specialist accreditation in pediatric medicine (2012 Singapore)
  • Specialist accreditation in pediatric nephrology (2017 Singapore)

Professional Appointments and Committee Memberships

  • Adjunct Assistant Professor, Duke-NUS Medical School
  • Adjunct Assistant Professor, Yong Loo Lin School of Medicine, National University of Singapore
  • Adjunct Instructor, Lee Kong Chian School of Medicine
  • Clinical Faculty Member, Pediatrics Residency Program
  • Member, RCPCH (UK)
  • Adjunct Assistant Professor, Duke-NUS Graduate Medical School Singapore
  • Adjunct Assistant Professor, Yong Loo Lin School of Medicine (NUS)
  • Clinical tutor, LKC-SOM
  • Clinical Faculty, Singapore pedaitrics residency program
  • Quality Improvement Champion, KK Women’s and Children’s Hospital

Awards

  • Singhealth Health Manpower Development Plan (HMDP) Award 2009
  • Singhealth Long Service Award 2017
  • KK Women’s and Children’s Hospital Long Service Award 2017

Research Interests

Publications

  • A Journey Gone Wrong: Mass In The Thorax. Chong SL. International Medical Journal. June 2012;11(1) 69-70
  • Graft Dysfunction After Kidney Transplantation In An Adolescent. Badria Al Ghaithi, Siew-Le Chong, Reham Al Mardini, Seetha Radhakrishnan, Rohan John, Lisa A Robinson. Am J Kidney Dis. 2013; 61(6):xxii-xxv
  • An Unusual Cause of Mediastinal Mass-A Case Report and Literature Review of Intrathoracic Kidney. SL Chong, SM Chao. Proceedings of Singapore Healthcare. 2012; 21(2): 144-150
  • Severe Acute Kidney Injury From Renal Calculi Due To Adenine Phosphoribosyltransferase Deficiency SL Chong, YH Ng. World Journal of Pediatrics. Dec 2015; DOI 10.1007/s12519-015-0073-8

Research Trials

  • Safety and Efficiacy of Paricalcitol capsules in Decreasing Serum intact Parathyroid Hormone Levels in Pediatric Subjects ages 10-16 years with moderate to severe Chronic Kidney Disease (Abbot Protocol M10-149, Co-investigator, completed)
  • A Multicenter, open label, 18 month study to evaluate the long-term safety and tolerability of valsartan in children 6 to 17 years of age with hypertension and with or without chronic kidney disease (CVAL489K2305, Co-investigator, completed)
  • Genetic analysis of primary glomerular diseases in children, adolescents and young adults in Asia (KKH Site Primary-investigator, Collaboration with Department of Paediatrics, Paediatric Nephrology Team, National University Hospital, ongoing)